Not exact matches
«On its own,» Beltran said, «a TNF - inhibitor might not be a cure, but it could be used complementary to
gene therapy, either
by slowing the course of
degeneration before the corrective
gene therapy is delivered or in combination with the corrective
gene therapy.»
Targeted
gene therapy for degenerative blindness caused
by Leber congenital amaurosis improved vision for a few years but failed to arrest the
degeneration process.
The findings
by Dr. Pang and his colleagues indicated that
gene therapy might be able to stop cone
degeneration during early Leber congenital amaurosis and restore the function and morphology of the cones still surviving in later stages of human LCA.